About Hempsana
Hempsana is a company based in Toronto (Canada) founded in 2018 by Randy Ko and Sohil Mana. Hempsana has raised $1.31 million across 2 funding rounds from investors including Quinsam Capital. The company has 3 employees as of December 31, 2024. Hempsana operates in a competitive market with competitors including Hyasynth Bio, IGC Pharma, Soul Biotech, Pike Therapeutics and Nura Lyfe Sciences, among others.
- Headquarter Toronto, Canada
- Employees 3 as on 31 Dec, 2024
- Founders Randy Ko, Sohil Mana
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.31 M (USD)
in 2 rounds
-
Latest Funding Round
$834.07 K (USD), Seed
Mar 18, 2021
- Investors
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Hempsana
Hempsana has successfully raised a total of $1.31M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $834.07 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Hempsana
Hempsana has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Quinsam Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management is focused on the cannabis industry.
|
Locked | Locked | Locked |
Investor details for Hempsana
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hempsana
Investment portfolio details for Hempsana
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hempsana
Detailed financials for Hempsana
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hempsana Comparisons
Peer comparison for Hempsana
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hempsana
Hempsana operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hyasynth Bio, IGC Pharma, Soul Biotech, Pike Therapeutics and Nura Lyfe Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cannabinoid products intended to treat neurological disorders
|
|
| Locked | Locked | Locked |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| Locked | Locked | Locked |
Psychedelics, mushrooms, and cannabinoids are developed for mental health treatments.
|
|
| Locked | Locked | Locked |
Developer of psychedelic and cannabinoid therapeutics
|
|
| Locked | Locked | Locked |
Delivers comprehensive psychedelic and cannabinoid therapeutics for neurological disorders.
|
Detailed competitors of Hempsana
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hempsana
Complete news archive for Hempsana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hempsana
Hempsana was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Hempsana is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Randy Ko is the current CEO of Hempsana. They have also founded this company.
Hempsana is a funded company, having raised a total of $1.31M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Hempsana is 3.
Hempsana was established in 2018 in Toronto, Canada, within the hemp processing sector. Solutions for extracting CBD oil from hemp plants are offered to cultivators and producers. Operating models are developed to facilitate CBD derivation, supporting management of neurological disorders via endocannabinoid compounds. A co-pay program is provided to farmers, aiding production oversight and financial planning across operations.
Hempsana's top competitors include IGC Pharma, Hyasynth Bio and Pike Therapeutics.
Hempsana has 1 investor. Key investors include Quinsam Capital.